The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Boehringer Ingelheim; Hengrui Therapeutics; Lilly; Pfizer; Roche
Identification of osimertinib resistance mechanisms in Chinese NSCLC patients: Analysis from AURA17 trial.
 
Min Hu
Employment - AstraZeneca
 
Yi-Long Wu
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Roche
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst)
 
Xuehua Zhu
Employment - AstraZeneca
 
Yun Sun
Employment - AstraZeneca
 
Xuesong Lu
Employment - AstraZeneca
 
Jia Wang
Employment - AstraZeneca
 
Mengzhao Wang
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Yanqiu Zhao
No Relationships to Disclose
 
Yuankai Shi
No Relationships to Disclose
 
You Lu
Consulting or Advisory Role - AstraZeneca; Lilly; Pfizer; Roche
Research Funding - AstraZeneca
 
Meiqi Shi
No Relationships to Disclose
 
Helong Zhang
No Relationships to Disclose
 
Xiangning Huang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Zhijie Ding
Employment - AstraZeneca
 
George Chen
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Caicun Zhou
No Relationships to Disclose